Transgenic Plants And A Transient Transformation System For Genome-Wide Transcription Factor Target Discovery
US-2015067923-A1 · Mar 5, 2015 · US
US9464296B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9464296-B2 |
| Application number | US-201113044142-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 9, 2011 |
| Priority date | Mar 23, 2007 |
| Publication date | Oct 11, 2016 |
| Grant date | Oct 11, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCA1, GLK1 or bZIP1, operably linked to a plant-specific promote, wherein the CCA1, GLK1 or bZIP1 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In other embodiments, transgenic plants in which express a lower level of CCA1, GLK1 or bZIP1 are provided. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein.
Opening claim text (preview).
What is claimed is: 1. A transgenic plant that exhibits increased nitrogen-assimilation capacity as compared to a wild-type plant, the transgenic plant having a first gene construct comprising a polynucleotide encoding Arabidopsis Basic Leucine Zipper 1 (bZIP1) operatively linked to a first promoter with activity in plants, and a second gene construct comprising a polynucleotide encoding Arabidopsis Golden 2-like 1 (GLK1) operatively linked to a second promoter with activity in plants, wherein the first and second promoters are optionally (a) a constitutive, tissue-specific, or inducible promoter or (b) associated with a constitutive or inducible regulatory element, and wherein the first and second promoters can be the same or different. 2. The transgenic plant of claim 1 , wherein the plant is a species of woody, ornamental, decorative, crop, cereal, fruit, or vegetable. 3. The transgenic plant of claim 1 , wherein the plant is a species of one of the following genuses: Acorus, Aegilops, Allium, Amborella, Antirrhinum, Apium, Arachis, Beta, Betula, Brassica, Capsicum, Ceratopteris, Citrus, Cryptomeria, Cycas, Descurainia, Eschscholzia, Eucalyptus, Glycine, Gossypium, Hedyotis, Helianthus, Hordeum, Ipomoea, Lactuca, Linum, Liriodendron, Lotus, Lupinus, Lycopersicon, Medicago, Mesembryanthemum, Nicotiana, Nuphar, Pennisetum, Persea, Phaseolus, Physcomitrella, Picea, Pinus, Poncirus, Populus, Prunus, Robinia, Rosa, Saccharum, Schedonorus, Secale, Sesamum, Solanum, Sorghum, Stevia, Thellungiella, Theobroma, Triphysaria, Triticum, Vitis, Zea , or Zinnia. 4. A method of producing a plant-derived commercial product using the transgenic plant according to claim 1 . 5. The method of producing a plant-derived commercial product of claim 4 , wherein said transgenic plant is a tree, and said commercial product is pulp, paper, a paper product, or lumber. 6. The method of producing a plant-derived commercial product of claim 4 , wherein said transgenic plant is tobacco, and said commercial product is a cigarette, cigar, or chewing tobacco. 7. The method of producing a plant-derived commercial product of claim 4 , wherein said transgenic plant is a crop, and said commercial product is a fruit or vegetable. 8. The method of producing a plant-derived commercial product of claim 4 , wherein said transgenic plant is a grain, and said commercial product is bread, flour, cereal, oat meal, or rice. 9. The transgenic plant of claim 1 , wherein the plant is a species of the genus Arabidopsis. 10. The transgenic plant of claim 1 , wherein the first and second promoters are constitutive promoters. 11. The transgenic plant of claim 1 , wherein the first and second promoters are inducible promoters. 12. The transgenic plant of claim 1 , wherein the first promoter is a seed-specific promoter. 13. The transgenic plant of claim 1 , wherein the second promoter is a leaf-specific promoter. 14. The transgenic plant of claim 12 , wherein the second promoter is a leaf-specific promoter. 15. The transgenic plant of claim 3 , wherein the first and second promoters are inducible promoters. 16. The transgenic plant of claim 3 , wherein the first promoter is a seed-specific promoter. 17. The transgenic plant of claim 3 , wherein the second promoter is a leaf-specific promoter. 18. The transgenic plant of claim 17 , wherein the second promoter is a leaf-specific promoter. 19. A method of producing a plant-derived commercial product using the transgenic plant according to claim 3 . 20. The method of producing a plant-derived commercial product of claim 19 , wherein said transgenic plant is a crop, and said commercial product is a fruit or vegetable.
Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation · CPC title
with agronomic (input) traits, e.g. crop yield · CPC title
involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title
from plants · CPC title
Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.